Abstract
Male MS Patients’ Safety, Tolerability and Efficacy Outcomes Do Not Differ from Female Patients Treated with Diroximel Fumarate: EVOLVE-MS-1 Ad-hoc Analysis (P8-3.017)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have